SRTA.US Strata Critical Medical, Inc.
- Market cap
- USD 468M
- P/E
- -
- P/B
- 1.75x
- ROE
- -7.7%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is SRTA.US undervalued?
Graham numberThe Graham number of Strata Critical Medical, Inc. cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Strata Critical Medical, Inc. fundamental analysis
No fundamental analysis for Strata Critical Medical, Inc. yet.
Strata Critical Medical, Inc. stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Strata Critical Medical, Inc.
Strata Critical Medical, Inc. provides time-critical logistics and medical services to the healthcare industry in the United States. It operates in two segments, Logistics and Clinical. The company offers logistics services, such as air and ground transportation for human organs, transplant teams, and related medical materials and organ placement services; transplant clinical services, including organ recovery procedures, normothermic regional perfusion, and preservation ser…
Full company profileStrata Critical Medical, Inc. financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Strata Critical Medical, Inc. annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 31.2M | 23.4M | 50.5M | 146M | 225M | 249M | 197M | 285M |
| Gross Profit | 4.70M | 2.33M | 10.5M | 22.3M | 42.1M | 58.9M | 41.1M | 61.5M |
| Operating Income | -11.5M | -10.4M | -24.1M | -53.5M | -68.1M | -33.9M | -22.4M | -16.3M |
| EBITDA | -11.1M | -9.83M | -43.1M | -22.3M | -50.4M | -21.6M | -5.71M | -11.3M |
| Net Income | -10.8M | -10.2M | -40.1M | -27.3M | -56.1M | -27.3M | 41.3M | -21.3M |
| EPS | -1.47 | -0.81 | -0.57 | -0.38 | -0.76 | -0.35 | 0.50 | -0.24 |
| Balance Sheet | ||||||||
| Total Assets | 278M | 17.7M | 336M | 325M | 295M | 257M | 325M | 329M |
| Total Liabilities | 273M | 6.64M | 44.5M | 50.5M | 60.6M | 34.7M | 46.4M | 52.5M |
| Shareholders' Equity | 5.00M | 11.1M | 291M | 274M | 234M | 222M | 279M | 276M |
| Cash & Short-term Investments | 278M | 12.2M | 282M | 192M | 166M | 127M | 61.2M | 41.6M |
| Total Debt | 463K | 1.89M | 716K | 18.3M | 24.5M | 9.32M | 3.31M | 3.62M |
| Cash Flow | ||||||||
| Operating Cash Flow | -10.3M | -10.8M | -15.6M | -37.1M | -32.3M | -2.52M | -48.9M | 24.9M |
| Capital Expenditure | 854K | 377K | 297K | 730K | 2.11M | 33.0M | 11.0M | 10.8M |
| Free Cash Flow | -11.2M | -11.2M | -15.9M | -37.9M | -34.5M | -35.5M | -59.9M | 14.2M |
| Ratios | ||||||||
| ROE | -216.8% | -91.7% | -13.7% | -9.9% | -23.9% | -12.3% | 14.8% | -7.7% |
| ROA | -3.9% | -57.4% | -11.9% | -8.4% | -19.0% | -10.6% | 12.7% | -6.5% |
| Net Profit Margin | -34.7% | -43.4% | -79.3% | -18.7% | -24.9% | -11.0% | 21.0% | -7.5% |
| Debt to Equity | 0.09x | 0.17x | 0.00x | 0.07x | 0.10x | 0.04x | 0.01x | 0.01x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Strata Critical Medical, Inc. dividends
Strata Critical Medical, Inc. has not paid dividends in the last 7 fiscal years.
Who owns Strata Critical Medical, Inc.
- Insiders 14.28%
- Institutions 73.05%
- Public & others 12.67%
- Shares outstanding 89.3M
- Free float 58.7M
Top funds holding SRTA.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| First Eagle Small Cap Opportunity I | 2.09M | 2.35% | +0.19% | Sep 2026 |
| Vanguard MStar Total Stk Mkt Idx Invest | 2.04M | 2.28% | 0.00% | Sep 2026 |
| iShares Russell 2000 ETF | 1.72M | 1.93% | 0.00% | Oct 2026 |
| Royce Small-Cap Growth Svc | 1.18M | 1.33% | 0.00% | Sep 2026 |
| Fidelity Small Cap Index | 750K | 0.84% | 0.00% | Aug 2026 |
| Royce Small-Cap Opportunity Invmt | 673K | 0.75% | +0.91% | Sep 2026 |
| Royce Small-Cap Trust | 647K | 0.72% | +18.29% | Sep 2026 |
| iShares Russell 2000 Value ETF | 642K | 0.72% | 0.00% | Oct 2026 |
| FTGF RY US SmCp Opp A USD Dis(A) | 601K | 0.67% | -1.86% | Oct 2026 |
| Vanguard Russell 2000 ETF | 397K | 0.44% | +1.38% | Sep 2026 |
| DFA U.S. Small Cap I | 380K | 0.43% | 0.00% | Sep 2026 |
| BNY Mellon VIF Small Cap Port Initl | 360K | 0.40% | 0.00% | Sep 2026 |
| Stt Strt® SPDR® S&P®HlthCrSvcsETF | 352K | 0.39% | 0.00% | Oct 2026 |
| Fidelity Extended Market Index | 330K | 0.37% | -6.76% | Sep 2026 |
| BNY Mellon Sm Cp Val I | 304K | 0.34% | 0.00% | Sep 2026 |
| Dimensional US Small Cap ETF | 284K | 0.32% | 0.00% | Oct 2026 |
| DFA US Micro Cap I | 252K | 0.28% | +8.55% | Sep 2026 |
| Dimensional US Core Equity 2 ETF | 238K | 0.27% | 0.00% | Oct 2026 |
| BNY Mellon Opportunistic Small Cap Inv | 222K | 0.25% | 0.00% | Jan 2026 |
| iShares Micro-Cap ETF | 207K | 0.23% | 0.00% | Oct 2026 |
Top institutions holding SRTA.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| Third Point, LLC | 5.00M | 5.60% | 0.00% | Jun 2026 |
| Becker Drapkin Management, L.P. | 4.89M | 5.48% | +19.57% | Jun 2026 |
| BlackRock Inc | 4.84M | 5.41% | +5.85% | Jun 2026 |
| Arnhold & S. Bleichroeder Advisers, LLC | 4.63M | 5.18% | +104.27% | Jun 2026 |
| Royce & Associates, LP | 3.13M | 3.51% | +11.24% | Jun 2026 |
| Vanguard Capital Management, LLC | 2.89M | 3.23% | +0.45% | Jun 2026 |
| Awm Investment Company Inc | 2.82M | 3.16% | 0.00% | Jun 2026 |
| ARK Investment Management LLC | 2.73M | 3.06% | -63.37% | Jun 2026 |
| Pillsbury Lake Capital LLC | 2.17M | 2.43% | -16.62% | Jun 2026 |
| Dimensional Fund Advisors, Inc. | 1.79M | 2.00% | +2.83% | Sep 2026 |
| Geode Capital Management, LLC | 1.76M | 1.97% | +3.28% | Jun 2026 |
| State Street Corp | 1.52M | 1.71% | +13.25% | Jun 2026 |
| Uniplan Investment Counsel, Inc. | 1.43M | 1.60% | +9.94% | Jun 2026 |
| Bank of New York Mellon Corp | 1.14M | 1.28% | +5.75% | Jun 2026 |
| Sumitomo Mitsui Trust Group Inc | 1.05M | 1.18% | -36.37% | Jun 2026 |
| Amova Asset Management Americas, Inc | 989K | 1.11% | -40.21% | Jun 2026 |
| Northern Trust Corp | 677K | 0.76% | +5.12% | Jun 2026 |
| Creek Drive Management Group LLC | 586K | 0.66% | -44.70% | Jun 2026 |
| Citigroup Inc | 527K | 0.59% | +445.21% | Jun 2026 |
| Vanguard Portfolio Management, LLC | 526K | 0.59% | +8.84% | Jun 2026 |
Strata Critical Medical, Inc. company profile
- Company name
- Strata Critical Medical, Inc.
- Ticker
- SRTA.US
- Exchange
- USA Stocks
- Listed since
- Aug 28, 2025
- Sector
- Healthcare
- Industry
- Ground Transportation
- Employees
- 327
- Fiscal year end
- December
- Address
- 666 Third Avenue, New York, NY, United States, 10017
- Phone
- (917) 781-3190
- Website
- stratacritical.com
About Strata Critical Medical, Inc.
Strata Critical Medical, Inc. provides time-critical logistics and medical services to the healthcare industry in the United States. It operates in two segments, Logistics and Clinical. The company offers logistics services, such as air and ground transportation for human organs, transplant teams, and related medical materials and organ placement services; transplant clinical services, including organ recovery procedures, normothermic regional perfusion, and preservation services. It also provides other clinical services comprising cardiac perfusion services, blood management and autotransfusion services, extracorporeal membrane oxygenation services, perfusion staffing, and equipment rentals. The company was formerly known as Blade Air Mobility, Inc. and changed its name to Strata Critical Medical, Inc. in August 2025. The company was founded in 2014 and is headquartered in New York, New York.
Strata Critical Medical, Inc. management
4- Ms. Melissa M. Tomkiel J.D.Co- CEO, General Counsel, Corporate Secretary & Director · born 1981
- Mr. William A. HeyburnCo-CEO, CFO & Director · born 1989
- Mr. Amir M. CohenChief Accounting & Integration Officer · born 1977
- Mr. Scott M. WunschChief Executive Officer of Logistics Services · born 1977